Sanford Health’s “cross-market” deal may allow it to avoid FTC scrutiny, experts say

Ben Remaly

30 October 2020

Shutterstock/Ken Wolter

The Federal Trade Commission is unlikely to challenge Sanford Health’s planned merger with Intermountain Healthcare, but the transaction may invite agency scrutiny following recent academic research, former FTC attorneys have said.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Senior news reporter, Global Competition Review

[email protected]

Tipline

Show us the money: The Tipline for 11 May 2021
Word on the street is that the US antitrust agencies may be receiving a windfall of cash from Congress – and most of the country's 56 other competition enforcers want in on the action. Attorneys general representing 45 states and territories sent a letter on Monday that urged antitrust leadership on Capitol Hill to remember that state antitrust enforcers act as complements to the Federal Trade Commission and the Department of Justice. It appears …
Some kind words: The Tipline for 10 May 2021
Tricky Dick: The Tipline for 7 May 2021

Sanford Health’s “cross-market” deal may allow it to avoid FTC scrutiny, experts say

Subscribe to Global Competition Review

Subscribe and start reading now

Already have access? Login below

Related Topics

Ben Remaly